Answers are grounded in this paper and cite their sources.
Background Herpes zoster (HZ) can impair wellbeing in older adults, but diagnoses recorded after illness do not necessarily indicate sustained within-person depressive symptom worsening. We examined symptom change using repeated questionnaires linked to dated HZ records. Methods This UK Biobank cohort analysis included 58399 adults aged 60 or older with three complete, ordered Patient Health Questionnaire-9 (PHQ-9) assessments from 2016 to 2022–2023 and no HZ before the first assessment. 323 developed HZ between assessments. Participant fixed-effects models, response weighting, an exploratory equivalence test and paired PHQ-9 > = 10 transitions assessed change and uncertainty. The age restriction was introduced during journal adaptation after the original all-age analysis. Results The fixed-effects difference was − 0.252 PHQ-9 points (95% confidence interval [CI] -0.499 to -0.004). The response-weighted difference was − 0.229 (-0.494 to 0.036). Equivalence within +/-0.308 points was not established (P = 0.327). Seven participants newly crossed PHQ-9 > = 10 and 12 remitted (exact paired P = 0.359). The adjusted risk ratio was 0.91 (0.55 to 1.50). A pre-event placebo analysis showed a higher probability of PHQ-9 > = 10 before future HZ (risk difference 3.69 (0.03 to 7.35) percentage points), limiting causal interpretation. Conclusions HZ onset was not followed by sustained average depressive symptom worsening at the available assessments in this selected older cohort. The small negative estimate does not establish a protective effect. Acute reactions, severe complications and clinically important effects in vulnerable subgroups remain unresolved.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: